PHARMA HOLDING ApS — Credit Rating and Financial Key Figures
CVR number: 32559174
Måløv Byvej 229, 2760 Måløv
anni@lifemedical.eu
tel: 21695777
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
External services | -51.89 | -11.77 | -14.47 | -1.80 | -15.80 |
Gross profit | -51.89 | -11.77 | -14.47 | -1.80 | -15.80 |
EBIT | -51.89 | -11.77 | -14.47 | -1.80 | -15.80 |
Other financial income | 0.02 | 0.13 | |||
Other financial expenses | -21.03 | -25.14 | -2.49 | -1.27 | -2.66 |
Reduction non-current investment assets | -2 445.38 | -0.00 | |||
Income from other inv. held as non-curr. assets | 5.33 | 14.27 | -13.61 | -2.89 | |
Net income from associates (fin.) | 2 121.90 | 239.53 | - 445.51 | 374.70 | -2 038.08 |
Pre-tax profit | 2 048.98 | 207.96 | - 448.21 | -2 087.33 | -2 059.31 |
Income taxes | 14.44 | 8.01 | -0.02 | 0.44 | |
Net earnings | 2 063.42 | 215.97 | - 448.23 | -2 086.89 | -2 059.31 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Holdings in group member companies | 4 058.30 | 2 297.84 | 1 852.33 | 2 227.03 | 188.95 |
Investments total | 4 058.30 | 2 297.84 | 1 852.33 | 2 227.03 | 188.95 |
Non-current loans receivable | 2 691.90 | 4 172.14 | 4 222.14 | 1 776.76 | 1 776.76 |
Long term receivables total | 2 691.90 | 4 172.14 | 4 222.14 | 1 776.76 | 1 776.76 |
Inventories total | |||||
Current other receivables | 1.00 | 0.00 | 1.00 | 1.00 | |
Current deferred tax assets | 616.06 | 73.46 | 90.00 | 58.00 | 42.00 |
Short term receivables total | 616.06 | 74.46 | 90.00 | 59.00 | 43.00 |
Other current investments | 30.26 | 5.95 | 20.21 | 6.61 | 3.72 |
Cash and bank deposits | 52.28 | 69.53 | 1.08 | 81.81 | 63.17 |
Cash and cash equivalents | 82.55 | 75.48 | 21.30 | 88.42 | 66.89 |
Balance sheet total (assets) | 7 448.81 | 6 619.91 | 6 185.77 | 4 151.22 | 2 075.60 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Shares repurchased | 56.50 | 57.20 | 58.90 | ||
Other reserves | 3 933.30 | 2 172.84 | 1 727.33 | 2 102.03 | 63.95 |
Retained earnings | 174.10 | 3 940.79 | 4 543.37 | 3 720.44 | 3 671.63 |
Profit of the financial year | 2 063.42 | 215.97 | - 448.23 | -2 086.89 | -2 059.31 |
Shareholders equity total | 6 277.33 | 6 436.80 | 5 931.37 | 3 785.58 | 1 726.28 |
Non-current liabilities total | |||||
Current trade creditors | 10.00 | 10.00 | 10.00 | ||
Current owed to group member | 1 169.28 | 122.21 | 109.19 | 176.43 | 155.93 |
Short-term deferred tax liabilities | 17.45 | 0.00 | |||
Other non-interest bearing current liabilities | 2.20 | 43.45 | 135.20 | 179.20 | 183.39 |
Current liabilities total | 1 171.49 | 183.11 | 254.39 | 365.63 | 349.32 |
Balance sheet total (liabilities) | 7 448.81 | 6 619.91 | 6 185.77 | 4 151.22 | 2 075.60 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.